Skip to main content

West Pharmaceutical Services United States revenue

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

United States revenue at West Pharmaceutical Services came to $1.3B for the fiscal year to 31 Dec 2025, up 8.0% from a year earlier.

As West Pharmaceutical Services reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 17 Feb 2026.

By fiscal year

$630.7MDec 2014$667.4MDec 2015$738.3MDec 2016$734.6MDec 2017$766.1MDec 2018$814.7MDec 2019$975.6MDec 2020$1.2BDec 2021$1.3BDec 2022$1.2BDec 2023$1.2BDec 2024$1.3BDec 2025
West Pharmaceutical Services United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
31 Dec 2025$1.3Bup 8.0%17 Feb 2026
31 Dec 2024$1.2Bdown 0.6%18 Feb 2025
31 Dec 2023$1.2Bdown 3.7%20 Feb 2024
31 Dec 2022$1.3Bup 7.4%21 Feb 2023
31 Dec 2021$1.2Bup 22.8%22 Feb 2022
31 Dec 2020$975.6Mup 19.7%23 Feb 2021
31 Dec 2019$814.7Mup 6.3%24 Feb 2020
31 Dec 2018$766.1Mup 4.3%28 Feb 2019
31 Dec 2017$734.6Mdown 0.5%26 Feb 2018
31 Dec 2016$738.3Mup 10.6%28 Feb 2017
31 Dec 2015$667.4Mup 5.8%26 Feb 2016
31 Dec 2014$630.7Mup 7.1%25 Feb 2015
31 Dec 2013$588.7Mdown 0.7%27 Feb 2014
31 Dec 2012$592.8Mup 9.1%27 Feb 2013
31 Dec 2011$543.6Mup 2.9%29 Feb 2012
31 Dec 2010$528.2M—28 Feb 2011

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of West Pharmaceutical Services: Proprietary Products revenue · West Vantage revenue · Germany revenue · Ireland revenue · FR revenue · financial statements

Every KPI and segment of WST, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.